Dept COVID-19 Update
Colleagues,
I wanted to update you on a few departmental and institutional activities, and to also express my gratitude for your generous and diligent support of one another and the needs of our patients.
PPE: A number of you have expressed legitimate concern about the restricted availability of PPE, particularly masks, beyond those healthcare workers with direct care responsibilities of COVID 19 confirmed or suspected cases. N95 masks for the ED personnel have recently been made available since they are at high risk. The rationale for making the difficult choice of not distributing masks to everyone include the following: this practice is not currently recommended by CDC and our ID advisors did not believe it was likely to be helpful; since our PPE supply, including masks is limited, conserving available supplies to avoid situations where we don't have sufficient PPE for high risk exposures is a priority. Partners decided to take that chance, we (and other health systems in Boston) did not; I was on a call yesterday with about 25 chairs of medicine-none of their institutions had gone to the full mask policy that Partners implemented. The rationale was the same as ours. The current policy is subject to ongoing revision as the PPE supply becomes clearer. I also wish we had enough masks for everyone but believe that BMC leadership made the correct decision under the circumstances. As to the approach for individuals wearing masks against policy, we decided against requiring staff to remove them despite the unintended message that selective wearing of masks may send. Major efforts are underway to address the PPE supply problem for the institution.
Staffing: Thanks to the hard work of our inpatient COVID teams, led by James Hudspeth, a contingency plan for the anticipated surge in COVID-infected patients is being developed. Our residents and faculty have been remarkably generous in providing coverage, volunteering for service, and supporting one another. The ICU and hospitalist attendings have been particularly effective and supportive in insuring the quality of care and in supervising our hard-working residents! BMC leadership has also been working diligently to expand our potential Med Surg and ICU capacity should the need arise. I anticipate that we will need to extend staffing beyond the usual inpatient medicine and intensive care attending and resident pools if the more extreme surge scenarios occur.
Financial Impact: The financial consequences of the COVID 19 epidemic are obviously being felt across all sectors of the economy, but particularly in the health care industry. The scale of impact across the country is so large that it seems highly likely that there will be some form of government support for the industry. BMC and our department are beginning to experience what is anticipated to be a sharp decline in clinical revenue. In addition, the distribution of clinical work across our department is highly variable-we have some clinicians who are working beyond their usual schedule under very stressful conditions and others who are under-utilized, particularly in the outpatient and procedural areas. It is critically important that we have a thoughtful, responsible, and fair approach to meeting the inevitable financial challenges before us. Therefore, we are forming a committee to develop a set of principles to maximize our ability to support our faculty and staff, and to secure the long-term future of the department. We hope to formulate a plan in the next few weeks. Meanwhile, BMC is seeking permission from the Board of Trustees to implement a furlough plan for BMC employees that seeks to offer some protection for the impacted employees while meeting the financial constraints of the institution.
Communication: The social isolation that we are experiencing is quite daunting. I have been reminded of how meaningful the social interactions are in my own professional life. I do hope to join with you in finding new ways to stay connected. I will hold a departmental faculty meeting via Zoom in the next few days. I encourage each of your sections to continue as many educational activities as possible during this period as well. Please offer any suggestions for how we can improve our communications in the department!
As we endure this unprecedented period of disruption in our personal and professional lives, I am inspired by your kindness and commitment to the noblest values of our profession. Thank you for your forbearance and for working so hard on behalf of our patients and one another. Our department will emerge from this experience wiser, appreciative, and fully prepared to soar into the future!
David Coleman, M.D.
From Cancer Patient to Medical Student
The clinical teams at Boston Medical Center provide interdisciplinary, compassionate care that saves lives.
DOM Experts Weigh-In on COVID-19
Joshua Barocas, MD, Infectious Diseases
WBUR
More Of Your Questions About The Coronavirus, Answered
Tamar Barlam, MD, Infectious Diseases
Boston Globe
Boston’s infectious disease specialists’ message to the public: Don’t be cavalier about the coronavirus
Nahid Bhadelia, MD, MA, Infectious Diseases
ABC News
Best practices to take action against COVID-19
Natasha S. Hochberg, MD, MPH, Infectious Diseases
WBUR
Your Questions About U.S. Travel And The Coronavirus, Answered
Thomas Perls, MD, Geriatrics
The Conversation
Social distancing: What it is and why it’s the best tool we have to fight the coronavirus
Caring for the Transgender Patient
Caring for the Transgender Patient: Grand Rounds Discussion From Beth Israel Deaconess Medical Center
By Howard Libman, MD; Joshua D. Safer, MD; Jennifer R. Siegel, MD; Eileen E. Reynolds, MD
In a recent Medical Grand Rounds at Beth Israel Deaconess Medical Center, Boston area leaders in care for transgender patients, including Jenny Siegel, MD, Assistant Professor of Medicine at Boston University School of Medicine, and Medical Director of the Center for Transgender Medicine and Surgery at Boston Medical Center, discuss critical components of the clinical guidelines for gender affirming hormones and surgery.
Clinical Guidelines
In the article, the following questions are posed to the panel of experts to discuss care guidelines in general and as they relate to the story of a particular patient considering gender-affirming care.
Conclusions
DOM Faculty Named 2020 Boston “Top Docs”
44 faculty members of the Department of Medicine have been named to Boston Magazine's annual Top Docs List.
Cardiac Electrophysiology
Robert Helm
Kevin Monahan
Cardiovascular Disease
Eric Awtry
Gary Balady
Sheilah Bernard
Robert Eberhardt
Alice Jacobs
Endocrinology, Diabetes
& Metabolism
Sonia Ananthakrishnan
Alan Farwell
Michael Holick
Stephanie Lee
Elizabeth Pearce
Gastroenterology
Charles Bliss
David Lichtenstein
Robert Lowe
David Nunes
Geriatric Medicine
Heidi Auerbach
Lisa Caruso
Hollis Day
Hematology
Vaishali Sanchorawala
Internal Medicine
Thomas Barber
Melissa DiPetrillo
Warren Hershman
Angela Jackson
Susan Phillips
Jeffrey Samet
Charles Tifft
Medical Oncology
Gretchen Gignac
Kevan Hartshorn
Matthew Kulke
Adam Lerner
Nephrology
Laurence Beck
Jasvinder Bhatia
Lauren Stern
Pulmonary Disease
John Berk
Jeffrey Berman
John Bernardo
Elizabeth Klings
Frederic Little
George O’Connor
Arthur Theodore
Rheumatology
David Felson
Eugene Kissin
Robert Simms
Will Massachusetts Ban Flavored Tobacco?
Dr. Hasmeena Kathuria, Associate Professor of Medicine in the Section of Pulmonary, Allergy and Sleep Medicine and director of the Tobacco Treatment Center at Boston Medical Center, joins State Sen. John Keenan on Radio Boston to discuss the future of a flavored tobacco ban now before the Massachusetts Senate. The proposal passed in the state's House of Representatives last week.
Listen to the Full Segment Here |
Dr. David Coleman to Receive Distinguished Chair of Medicine Award
Dr. David Coleman, Wade Professor and Chairman of Medicine, has been named the 2020 recipient of The Robert H. Williams, MD, Distinguished Chair of Medicine Award, presented by the Association of Professors of Medicine (APM).
From the Alliance for Academic Internal Medicine Announcement:
"Described as an “outstanding chair who has distinguished himself through service to his department and the academic internal medicine community,” Dr. Coleman’s “impact and reach are exceptional and his contributions to the tripartite missions of our profession – education, clinical care, and research – are extraordinary.” Examples of Dr. Coleman’s vision, systems thinking, and ability to lead change abound: from his passion for “providing exceptional clinical care despite the many impediments posed by social determinants of health” to his commitment to “placing the Department at the forefront of new and evolving research initiatives” to serving as “a champion for education, mentorship, faculty development, and diversity.” His dean notes that “he is one of my most trusted senior leaders; someone to whom I can turn for his innovative approaches to interdisciplinary collaborations and medical student education.”
Dr. Coleman has served as Chair of Medicine at Boston University School of Medicine and physician-in-chief at Boston Medical Center since 2006. During his tenure, the Department has seen tremendous growth in its research and clinical care portfolios and educational programming.
Read More |
Dr. Weining Lu Named BU Innovator of the Year
Dr. Weining Lu, associate professor in the section of Nephrology, has been named 2019 BU Innovator of the Year.
Dr. Lu's research focuses on the gene ROBO2 as it relates to a kidney’s filtering ability, and has led to a collaboration with Pfizer’s Centers for Therapeutic Innovation (CTI) since November 2012.
This unique collaboration between academia and industry on developing mechanisms to affect ROBO2 function in adults will have far reaching impacts on the 37 million people in the US and 850 million people worldwide with chronic kidney disease.
Read Full Article in the Brink |
Removing Unnecessary Contact Isolation Precautions
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that can be transmitted via skin-to-skin contact and may cause severe infections. BMC has a policy to place MRSA-colonized patients on contact isolation precautions. An estimated 15-30% of colonized patients clear within 90 days giving us the opportunity to reduce the need for private rooms, improve staff and patient satisfaction by reducing need for protective gear, minimize “isolation precaution fatigue”, and save an estimated $6.4 million/year by removing unnecessary MRSA precautions.
Eligible MRSA positive adults for rescreening are those:
- With no positive MRSA PCR or culture in the prior 90 days, and
- Who do not have an active antibiotic order.
A Best Practice Advisory Logic has been introduced to Admission Order Sets to facilitate removal MRSA precautions in eligible patients. This logic looks at patients previously identified as MRSA positive to begin a re-screening process at admission. The order is two-step testing, once on the day of the order and the second 48 hrs later if the first test is negative.
If both screens/cultures come back negative, please e-mail DG-Infection Prevention and isolation precautions will be removed.
PLEASE ONLY DE-SELECT ORDERS if patient is currently on antibiotics.
Resident Corner Fall ’19
STARS Candy Rounds by Swetha Ramachandran, MD and the QIPS Residents
As part of the internal medicine residency program at BMC, there is a Quality Improvement and Patient Safety (QIPS) pathway for residents who are interested in identifying patient safety issues and improving outcomes using quality improvement methodologies. This year the residents in the QIPS pathway are working to promote resident participation in quality improvement initiatives.
To achieve this goal, we have started weekly patient safety rounds where a QIPS resident will touch base with medicine teams in person to inquire about patient safety issues that the teams have encountered in the hospital. With these weekly rounds, we hope to increase resident STARS reporting and patient safety awareness.
Additionally, each week a STARS report will be reviewed by a QIPS resident with the aim of improving recurrent systems issues as well as providing feedback to the reporting provider. As a group, the QIPS pathwa
y residents are excited and motivated to make changes that will improve patient care and streamline hospital processes.